ArticleScientific reports2025
Evaluation of antiarrhythmia drug through QSPR modeling and multi criteria decision analysis.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Exploring anticancer drug structures through vertex based resolving parameters.Scientific reports · 2026Article
- On machine learning based QSPR analysis of amphetamine derivatives using regression models.Scientific reports · 2026Article
- TOPSIS based multi criteria QSPR modeling of antibiotics using graph theoretic indices.Scientific reports · 2025Article
- Multi criterion decision making analysis of hematologic cancer drugs via topological indices and physicochemical properties.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study explores how topological indices (TIs), which are mathematical descriptors of a drug's molecular structure, can support to predict vital properties and biological activities. This understanding is a key for more effective drug design. We focused on drugs used to treat several arrhythmia conditions, including tachycardias, bradycardias, and premature beats. Our approach combines molecular modeling with decision-making techniques to offer a cost-effective way to understand how these drug molecules behave. Our procedure started with calculating topological indices for the chemical structures of these medications to extract information about their features. We then established quantitative structure-property relationship (QSPR) models using quadratic regression, training and validating them. We concentrated on TIs that showed a strong correlation[Formula: see text] with physicochemical properties. Each property was also weighted, based on its correlation with the topological indices. As a final point, to aid in informed decision-making, we employed multiple-criteria decision-making approaches Technique for Order Preference by Similarity to Ideal Solution TOPSIS and Simple Additive Weighting SAW to rank the anti- arrhythmia medications. Drug Amiodarone ranked highest due to strong correlation with boiling point and polarizability. The study also highlights the potential of machine learning to analyze large datasets, allowing for accurate predictions of chemical behavior. This comprehensive method can facilitate the detection of new drugs with valuable qualities and improve our understanding of how chemical structures affect drug effectiveness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.